Among 19 neuroblastoma patients treated with CAR T-cell therapy, eight survived more than 5 years after infusion, including ...

Helen Heslop and colleagues conducted a phase 1 clinical trial involving 19 children with neuroblastoma, between 2004 and ...

Heslop’s team recruited 19 children with neuroblastoma — 11 with actively growing cancer and eight who were at high risk of relapsing. From 2004 to 2009, all 19 were infused with CAR-T cells.

A woman who underwent a trial immunotherapy as a child for neuroblastoma — an aggressive nerve tissue tumor that occurs often in children under 5 — has since been in remission for 18 years.

Professor Helen Heslop, who led the trial, said: 'It's nice to have such long-term follow-up and to see that even if it was a very early CAR T-cell – and there's been a lot of work to make them ...

Helen Heslop, M.D., DSC, Professor of Medicine and Pediatrics and Director of the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist Hospital, ...

Among 19 neuroblastoma patients treated with CAR T-cell therapy, eight survived more than 5 years after infusion, including five with follow-up of more than 13 years, reported Helen Heslop, MD, of ...

A woman who underwent a trial immunotherapy as a child for neuroblastoma — an aggressive nerve tissue tumor that occurs often in children under 5 — has since been in remission for 18 years ...